Lactose (India) Ltd | 133 Cr. | 94.1 | 247/84.3 | 25.7 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 5.03 Cr. | 2.63 | 4.33/2.50 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 40.8 Cr. | 55.0 | 94.9/44.5 | | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 33.5 Cr. | 22.8 | 29.1/13.1 | 32.8 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 74.2 Cr. | 98.5 | 155/79.0 | 16.9 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 44,441 Cr. | 1,575 | 1,831/1,161 | 33.7 | 314 | 0.17 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 302 Cr. | 13.3 | 29.0/11.2 | 18.7 | 8.21 | 0.00 % | 12.5 % | 9.03 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.44 Cr. | 13.3 | 27.1/9.25 | 80.5 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 346 Cr. | 732 | 956/635 | 16.6 | 277 | 0.10 % | 22.3 % | 17.1 % | 10.0 |
Fervent Synergies Ltd | 95.5 Cr. | 21.8 | 32.0/14.6 | 32.4 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 953 Cr. | 324 | 449/153 | 12.5 | 123 | 0.39 % | 21.7 % | 23.4 % | 5.00 |
Fabino Enterprises Ltd | 5.20 Cr. | 24.8 | 36.5/22.8 | 40.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 10.7 Cr. | 4.28 | 12.3/2.11 | 118 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 404 Cr. | 416 | 477/112 | | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,299 Cr. | 1,218 | 1,584/1,009 | 55.9 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 208 Cr. | 2.24 | 2.72/1.03 | 27.7 | 2.24 | 0.00 % | 4.21 % | 5.69 % | 2.00 |
Dipna Pharmachem Ltd | 55.6 Cr. | 23.1 | 26.3/6.40 | 67.0 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.3 Cr. | 11.2 | 24.6/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 219 Cr. | 613 | 999/488 | 8.85 | 563 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 32.0 Cr. | 32.0 | 45.0/26.1 | 107 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 28.0 Cr. | 61.3 | 88.7/39.9 | 56.1 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 10.1 Cr. | 4.05 | 26.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 19.2 Cr. | 128 | 154/55.1 | 56.6 | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 10.0 Cr. | 18.3 | 28.9/6.08 | 333 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 42.2 Cr. | 56.0 | 111/46.2 | 49.1 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 4.92 Cr. | 16.4 | 27.8/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 15,667 Cr. | 902 | 969/370 | 51.3 | 65.3 | 0.11 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 112 Cr. | 26.0 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 9.89 Cr. | 19.5 | 46.0/17.4 | 17.0 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 146 Cr. | 254 | 418/241 | 15.8 | 119 | 1.77 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 24.5 Cr. | 41.6 | 62.6/14.8 | 61.2 | 43.2 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 67,984 Cr. | 1,160 | 1,593/994 | 19.5 | 557 | 0.39 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 175 Cr. | 281 | 300/156 | 95.3 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 1,058 Cr. | 211 | 250/148 | 22.4 | 65.1 | 1.18 % | 19.5 % | 15.3 % | 5.00 |
ANG Lifesciences India Ltd | 38.9 Cr. | 29.8 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Ami Organics Ltd | 9,630 Cr. | 1,176 | 1,322/504 | 60.7 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.75 Cr. | 0.87 | 1.45/0.58 | 575 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 275 Cr. | 35.9 | 77.7/34.1 | 27.4 | 18.3 | 0.00 % | 8.60 % | 7.23 % | 10.0 |
Adline Chem Lab Ltd | 9.24 Cr. | 15.8 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 82.4 Cr. | 3.50 | 6.25/2.82 | 150 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 66,927 Cr. | 31,500 | 32,200/25,260 | 47.3 | 1,992 | 1.31 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 8,252 Cr. | 910 | 950/521 | 30.3 | 220 | 0.33 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 157 Cr. | 55.4 | 75.8/31.3 | 39.0 | 48.8 | 0.00 % | 6.00 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 2,771 Cr. | 942 | 1,078/468 | | 78.1 | 0.11 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 24,509 Cr. | 1,508 | 1,680/545 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 997 Cr. | 302 | 330/144 | 32.7 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 570 Cr. | 430 | 477/270 | 14.6 | 420 | 0.00 % | 11.4 % | 7.45 % | 10.0 |
Unichem Laboratories Ltd | 4,181 Cr. | 595 | 950/510 | 30.4 | 348 | 0.00 % | 6.36 % | 5.71 % | 2.00 |
TTK Healthcare Ltd | 1,730 Cr. | 1,221 | 1,923/991 | 24.3 | 754 | 0.82 % | 9.25 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,06,573 Cr. | 3,151 | 3,591/2,755 | 55.3 | 224 | 1.01 % | 27.2 % | 26.7 % | 5.00 |
Themis Medicare Ltd | 1,258 Cr. | 137 | 317/115 | 42.2 | 43.7 | 0.36 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,962 Cr. | 20.8 | 27.9/12.0 | 40.1 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 4,811 Cr. | 221 | 257/94.8 | | 5.04 | 0.00 % | 84.4 % | 84.6 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,03,040 Cr. | 1,680 | 1,960/1,461 | 35.2 | 301 | 0.80 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,113 Cr. | 476 | 886/417 | 3,913 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,168 Cr. | 245 | 398/175 | 31.7 | 75.9 | 0.16 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 389 Cr. | 1,290 | 1,750/744 | 20.8 | 650 | 0.12 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 8,979 Cr. | 917 | 960/518 | 100 | 243 | 0.00 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,709 Cr. | 188 | 241/111 | 213 | 28.1 | 0.00 % | 8.97 % | 3.25 % | 2.00 |
Sanofi India Ltd | 14,167 Cr. | 6,153 | 7,600/4,146 | 37.3 | 374 | 1.90 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,535 Cr. | 2,136 | 2,977/1,439 | 29.9 | 321 | 0.75 % | 33.3 % | 26.1 % | 8.00 |
Procter & Gamble Health Ltd | 9,205 Cr. | 5,543 | 5,944/4,863 | 35.4 | 323 | 1.44 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 205 Cr. | 58.0 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 26,054 Cr. | 5,696 | 6,453/3,701 | 40.7 | 922 | 0.61 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 122 Cr. | 99.1 | 348/81.0 | 9.13 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,759 Cr. | 450 | 582/126 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,645 Cr. | 719 | 1,998/604 | 36.6 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 16,712 Cr. | 13,037 | 18,100/6,176 | 82.4 | 1,188 | 0.11 % | 18.2 % | 14.4 % | 10.0 |
Nectar Lifescience Ltd | 549 Cr. | 24.5 | 56.5/20.0 | 32.3 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 15,378 Cr. | 858 | 1,639/660 | 8.16 | 425 | 1.11 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 3,515 Cr. | 64.1 | 101/41.7 | 29.8 | 21.1 | 0.00 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 11,463 Cr. | 253 | 359/152 | 30.1 | 54.4 | 0.24 % | 20.1 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 127 Cr. | 80.5 | 145/70.1 | 18.4 | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 415 Cr. | 116 | 177/90.2 | 52.4 | 29.0 | 0.00 % | 9.93 % | 9.24 % | 10.0 |
Lupin Ltd | 91,061 Cr. | 1,994 | 2,403/1,531 | 27.8 | 377 | 0.40 % | 21.5 % | 20.8 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,146 Cr. | 572 | 980/499 | 13.9 | 335 | 0.32 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 34,617 Cr. | 642 | 661/390 | 102 | 84.6 | 0.19 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 964 Cr. | 929 | 1,070/481 | 24.2 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 209 Cr. | 96.0 | 129/63.6 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 933 Cr. | 193 | 370/155 | 24.2 | 107 | 1.55 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 721 Cr. | 443 | 500/271 | 28.9 | 126 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 18,100 Cr. | 1,135 | 1,310/701 | 32.6 | 393 | 0.44 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,438 Cr. | 1,694 | 2,030/1,303 | 40.1 | 221 | 0.72 % | 26.6 % | 20.8 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,545 Cr. | 233 | 328/126 | 38.8 | 36.1 | 0.86 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 34,612 Cr. | 1,365 | 1,758/1,052 | 39.9 | 274 | 0.29 % | 15.0 % | 13.1 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,600 Cr. | 88.6 | 108/57.5 | 25.7 | 57.5 | 1.13 % | 8.85 % | 6.12 % | 2.00 |
Ind-Swift Ltd | 91.0 Cr. | 17.0 | 34.7/12.0 | 1.41 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 562 Cr. | 92.7 | 186/67.2 | 6.79 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,527 Cr. | 274 | 388/190 | | 111 | 0.55 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 4,589 Cr. | 372 | 465/285 | 50.5 | 102 | 0.32 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,581 Cr. | 1,849 | 3,379/1,243 | 57.5 | 369 | 0.32 % | 9.62 % | 9.07 % | 10.0 |
Gufic BioSciences Ltd | 3,689 Cr. | 369 | 504/285 | 52.7 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 12,872 Cr. | 531 | 725/412 | 26.9 | 153 | 0.28 % | 15.1 % | 13.8 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 44,861 Cr. | 1,590 | 1,831/1,176 | 34.0 | 314 | 0.16 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 58,036 Cr. | 3,419 | 3,516/1,921 | 62.8 | 115 | 1.23 % | 66.9 % | 49.6 % | 10.0 |
Gland Pharma Ltd | 26,944 Cr. | 1,632 | 2,221/1,200 | 24.7 | 592 | 1.23 % | 15.9 % | 11.6 % | 1.00 |
FDC Ltd | 6,967 Cr. | 428 | 659/359 | 26.1 | 140 | 1.16 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 22,218 Cr. | 1,634 | 1,664/977 | 63.2 | 210 | 0.45 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,10,250 Cr. | 1,320 | 1,421/1,020 | 19.5 | 402 | 0.61 % | 23.1 % | 18.3 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,201 Cr. | 268 | 308/144 | | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,21,214 Cr. | 1,501 | 1,702/1,310 | 23.0 | 386 | 0.86 % | 23.3 % | 18.2 % | 2.00 |
Caplin Point Laboratories Ltd | 15,918 Cr. | 2,091 | 2,641/1,280 | 29.7 | 375 | 0.24 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 388 Cr. | 133 | 203/75.0 | | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,442 Cr. | 137 | 186/101 | 17.1 | 99.7 | 0.37 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 86.5 Cr. | 53.5 | 92.0/40.4 | 154 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 39,626 Cr. | 330 | 405/291 | 41.2 | 180 | 0.15 % | 6.13 % | 4.64 % | 5.00 |
Beta Drugs Ltd | 1,850 Cr. | 1,832 | 2,215/1,119 | 40.4 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 159 Cr. | 100 | 158/76.3 | 22.0 | 48.6 | 1.19 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 173 Cr. | 73.0 | 96.0/67.8 | 27.4 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 24,382 Cr. | 9,760 | 10,050/6,070 | 139 | 308 | 0.25 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,062 Cr. | 714 | 863/544 | 40.6 | 113 | 0.64 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 208 Cr. | 99.0 | 145/80.3 | 10.6 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 58,145 Cr. | 4,860 | 6,440/4,492 | 26.8 | 1,002 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 19,424 Cr. | 988 | 1,304/725 | 34.0 | 264 | 1.11 % | 13.1 % | 11.4 % | 2.00 |
Albert David Ltd | 461 Cr. | 806 | 1,754/763 | 26.8 | 688 | 1.43 % | 6.48 % | 4.44 % | 10.0 |
Ajanta Pharma Ltd | 32,148 Cr. | 2,571 | 3,486/2,022 | 34.9 | 290 | 1.40 % | 33.3 % | 25.6 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,393 Cr. | 303 | 571/258 | 25.9 | 127 | 1.32 % | 13.0 % | 9.55 % | 2.00 |
Aarti Drugs Limited | 4,248 Cr. | 462 | 635/312 | 27.0 | 136 | 0.22 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,620.20 Cr | 1,165.22 | | 89.13 | 194.54 | 0.31% | 16.73% | 15.23% | 6.19 |